Skip to content
Independent analysis of NHS open data
PharmaInsight

Glecaprevir/pibrentasvir

Infections Antiviral drugs BNF 0503032K0
Data updated May 2025 Download CSV
8items

Dispensed in May 2025

0items

Rolling 12 months

£25,987

Net ingredient cost · May 2025

Figure 1. Glecaprevir/pibrentasvir: national items dispensed by month

0 4 8 Oct 2021 Nov 2021 Dec 2021 Jan 2022 Feb 2022 Mar 2022 May 2025 8 Oct 2021: 1 Nov 2021: 1 Dec 2021: 1 Jan 2022: 1 Feb 2022: 1 Mar 2022: 1 May 2025: 8

Source: NHSBSA Prescription Cost Analysis, to May 2025

Download CSV
Embed this chart

At a glance

  • Therapeutic class Antiviral drugs
  • Presentations 1 shown
  • Average cost / item £3,248.42
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, May 2025

The individual products dispensed under Glecaprevir/pibrentasvir this month.

Presentations of Glecaprevir/pibrentasvir, May 2025
Presentation BNF code Items Net ingredient cost
Glecaprevir 100mg / Pibrentasvir 40mg tablets 0503032K0AAAAAA 8 £25,987

Source: NHSBSA Prescription Cost Analysis · to May 2025 OGL v3.0

Where Glecaprevir/pibrentasvir is dispensed

The regions and dispensing practices with the highest Glecaprevir/pibrentasvir volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

Compare Glecaprevir/pibrentasvir with

Other medicines in the same BNF section, by prescribing volume.